SciClone Pharmaceuticals Competitors and Similar CompaniesClear all
SciClone Pharmaceuticals's competitors and similar companies include dMed and EyePoint Pharmaceuticals.
 SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | |
Founding Date | Founding Date 1989 | Founding Date 2016 | Founding Date 1987 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Foster City, US HQ | Locations Morrisville, US HQ | Locations Watertown, US HQ |
Employees | Employees 1102% decrease | Employees 172 | Employees 8453% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $160.1m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) $31.4m (FY, 2025) |
Net income | Net income $30.7m (FY, 2016) | Net income N/A | Net income ($232m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 208m | Total funding raised $ 40m |
For sources of this data, please see the company profile
View Company Profiles
dMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View companyEyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company